TomorrowsRX Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10
Best for: people who want low per-month prices on prepaid compounded semaglutide or tirzepatide supplies
TomorrowsRX scores highest on the strength of its clinical program: drug options and dosing support.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
TomorrowsRX is a California online health store that sells compounded semaglutide and tirzepatide alongside sexual health, hair, hormone and longevity treatments, with clinicians from the MD Integrations network. At checkout, a 1-month semaglutide supply is $190 and tirzepatide is $239, with 3, 6 and 12 month supplies paid up front for less per month. Its product pages list different prices than its checkout.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to TomorrowsRX
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
TomorrowsRX at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $190/mo
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored TomorrowsRX
Each dimension is scored algorithmically from TomorrowsRX’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
7.6/10At $190/mo, TomorrowsRX runs in line with the $185 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.8/10TomorrowsRX offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.1/10Online intake and platform experience (consult included in the price); 8 platform features disclosed.
Trust & Safety15%
7.0/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
6.2/10TomorrowsRX's exact state footprint isn't published. Confirm coverage in your state before signing up. FSA/HSA cards are accepted.
Support10%
5.6/10TomorrowsRX provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this TomorrowsRX review
Last checked November 2026- Confirmed current pricing across 8 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $99–$239/mo across 8 dose/plan tiers (checked November 2026)
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with TomorrowsRX
We walked TomorrowsRX’s public signup flow in November 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Pick a treatment from the shop and choose a 1, 3, 6 or 12 month supply
- 2Add it to the cart and select Proceed to Checkout
- 3Checkout asks for your contact details and shipping address, then payment
- 4After you order, you complete an online health assessment and upload a photo ID and selfie
- 5A clinician reviews your answers, usually within 24 hours; some states need a live chat or video visit
- The cart showed $149.97 for one month of the semaglutide item, but checkout showed $190 for 'Semaglutide - 1 month supply'
- Checkout lists 'Doctor Support and Monitoring' and overnight shipping as free
- Product pages call the drugs 'Compounded GLP-1' and 'Advanced GLP-1 + GIP'; checkout names semaglutide and tirzepatide
- The homepage promises a 365-day guarantee, while the returns page says prescription sales are final
- You can ask to send your prescription to a pharmacy of your choice by emailing support before ordering
TomorrowsRX customer support
- Phone
- +1 844 790 1553
- care@tomorrowsrx.com
GLP-1 medications TomorrowsRX offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Checkout total for 'Semaglutide - 1 month supply' is $190. The product page lists this item as $149.97 for the first month, then $249.97 a month.
Checkout total $399 for 'Semaglutide - 3 months supply', about $133 a month. The product page lists $449.97.
Checkout total $714 for 'Semaglutide - 6 months supply', $119 a month. The product page lists $809.95.
Checkout total $1,188 for 'Semaglutide - 12 months supply', $99 a month. The product page lists $1,349.97.
Checkout total for 'Tirzepatide - 1 month supply' is $239. The product page ('Advanced GLP-1 + GIP') lists $249.97 for the first month, then $349.97 a month.
Checkout total $589 for 'Tirzepatide - 3 months supply', about $196 a month. The product page lists $749.97.
Checkout total $1,074 for 'Tirzepatide - 6 months supply', $179 a month. The product page lists $1,349.82.
Checkout total $1,788 for 'Tirzepatide - 12 months supply', $149 a month. The product page lists $2,349.88.
Ready to get started?
Plans and promotions change often, so check TomorrowsRX's current pricing and active discounts before you decide.
What we like
- Prices are shown before any health questions, and the checkout names the drug and supply length
- Low per-month cost on the longer plans: semaglutide is $99 a month on the 12-month supply
- Names its compounding pharmacies, Manifest Pharmacy and RX Compounding Store, and its clinician network
- No upcharge on higher doses, with the consult and shipping included
- LegitScript seal served from LegitScript's own site
- Reachable by phone, email and a contact form
Watch-outs
- Product pages and checkout show different prices for the same supply, so check the checkout total
- Product pages say 'Compounded GLP-1' and 'Advanced GLP-1 + GIP'; the drug name appears only at checkout
- Advertises a 365-day money-back guarantee, but the returns policy says prescription sales are final
- The FAQ gives two different answers on whether you are charged at checkout or when the order ships
- The longer supplies are paid in full up front
- No Trustpilot profile, and homepage reviews are first names with no source
- Disputes go to binding arbitration in San Diego
Is TomorrowsRX worth it?
TomorrowsRX is aimed squarely at people who want low per-month prices on prepaid compounded semaglutide or tirzepatide supplies. It runs $190/month at every dose, squarely in the middle of what this category charges, so what you get for it matters more here than the number itself. Its flat, all-dose pricing helps anyone worried about cost climbing as they titrate up.
It is LegitScript-certified. It also names the pharmacy that fills its prescriptions and takes HSA/FSA payment.
How much TomorrowsRX costs
Compounded semaglutide runs $99–$190/month depending on plan, the low end a 12-month plan rate, and compounded tirzepatide runs $149–$239/month depending on plan, the low end a 12-month plan rate.
That's roughly in line with the ~$185/month median across the GLP-1 providers we track (each program's lowest listed ongoing monthly price for compounded semaglutide).
For a direct comparison, Brightmeds runs semaglutide and tirzepatide from $189/month, so compare it with TomorrowsRX before you commit.
Medications: what TomorrowsRX prescribes
TomorrowsRX prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two molecules with the strongest published weight-loss trial outcomes. Rather than brand-name pens, you get a compounded formulation from a licensed pharmacy, which is why the monthly cost is lower. Just know compounded drugs aren't FDA-approved as finished products, the standard caveat in this market.
Who TomorrowsRX is best for, and who should skip it
A good fit if you…
- want a straightforward telehealth GLP-1 program and are comfortable comparing it against the alternatives below.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement, so read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
TomorrowsRX is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding.
The Bottom Line
TomorrowsRX scores highest on the strength of its clinical program: drug options and dosing support.
Ready to start with TomorrowsRX?
From $190/mo. See current pricing and start your free consultation.
TomorrowsRX might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare TomorrowsRX vs…
TomorrowsRX scores7.1/10
Side-by-side pricing, medications and scores. Pick a matchup.
TomorrowsRX vs Amazon One Medical
Amazon One Medical scores 8.5/10

TomorrowsRX vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this TomorrowsRX review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See TomorrowsRX's current pricing
Plans from $190/mo. Start your free consultation to check eligibility and today's price.